Radalara Receives IRB Approval for Novel Radiation-Safety Study at Houston Methodist Hospital
Houston, TX October 20, 2025 – Radalara, a pioneering healthcare technology company focused on reducing radiation exposure in interventional suites, today announced the approval of an Institutional Review Board (IRB)-approved study at Houston Methodist Hospital. This milestone marks a significant step forward in validating Radalara's innovative computer vision device, which uses predictive analytics to forecast potential scatter radiation and enhance safety for operating room (OR) personnel from the dangers of ionizing radiation.Houston Methodist Hospital, ranked as the top hospital in Texas by U.S. News & World Report , is renowned for its cutting-edge research and commitment to patient and staff safety. The study will test Radalara's proactive technology in real-world interventional procedures, where X-ray exposure poses ongoing risks to medical teams.Radalara (Radiation As Low As Reasonably Achievable) addresses a critical gap in current radiation monitoring systems, which are often reactive and report exposures after the fact - sometimes months later. The Radalara device predictive software allows users to modify behaviors and minimize exposure prior to the radiating event."Partnering with a top-tier institution like Houston Methodist underscores the potential of Radalara to transform radiation safety in healthcare," said Ezekiel Fink, MD, Co-Founder of Radalara. "As a fluoroscopy expert, I am concerned about the long-term health impacts of cumulative low-dose radiation on vast numbers of healthcare professionals who work in close proximity to radiation and patients who are exposed to radiation in medical settings. This IRB-approved study will provide essential data to refine our technology with the goal of improving safety ."The company has a working prototype, multiple patents filed with a filed non-provisional patent granted, and a clear path to FDA approval.About RadalaraRadalara, an HSPM Group company, is dedicated to advancing radiation safety through innovative, predictive technology. By enabling real-time exposure reduction, we protect healthcare professionals and improve outcomes in interventional suites.Media Contact:
Dr. Ezekiel Fink
HSPM Group